Skip to main content
. Author manuscript; available in PMC: 2016 May 18.
Published in final edited form as: Int J Obes (Lond). 2015 Oct 7;40(4):601–606. doi: 10.1038/ijo.2015.207

Table 1.

Baseline Characteristics (n=76)

Variable Frequency
Obesity status (normal/overweight/obese) (11/15/50)
Sex (M/F) (40/36)
Tanner stage (2/3/4/5) (34/5/7/40)

Mean ± SEM

Age (yrs) 16.1 ± 0.5
Height (cm) 160.3 ± 1.5
Weight (kg) 79.6 ± 2.8
BMI (kg/m2) 30.5 ± 0.8
BMI%ile* 93.6 ± 1.2
Total fat mass (kg) 27.7 ± 1.3
SAT (L) 6.1 ± 0.4
VAT (L) 1.6 ± 0.1
HFF (%) 6.5 ± 0.7
PFF (%) 4.6 ± 0.3
Fasting glucose (mg/dL) 90.2 ± 0.8
2-h glucose (mg/dL) 121.2 ± 2.3
Glucose AUCOGTT (mg/dL x min) 260.3 ± 3.5
HbA1c (%) 5.5 ± 0.0
Fasting Insulin (μU/mL) 8.3 ± 0.6
Insulin AUCOGTT (μU/mL x min) 234.0 ± 17.8
Mastuda Index (ISI) 4.1 ± 0.3
Insulinogenic Index (IGI) 3.1 ± 0.3
Disposition Index (ISI* IGI) 10.6 ± 1.0
Fasting FFA (mmol/L) 0.62 ± 0.02
FFA AUCOGTT (mmol/L x min) 0.66 ± 0.02
*

For participants ≤18 yrs.

BMI= body mass index, SAT= subcutaneous abdominal adipose tissue, VAT= visceral adipose tissue, HFF= hepatic fat fraction, PFF= pancreatic fat fraction, AUC= area under the curve, OGTT= oral glucose tolerance test, ISI= insulin sensitivity index, IGI= insulinogenic index, FFA= free fatty acid